Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 268
- McKinley Medical Centre Expands Access to Care for Children and Families
- Explosive $10 Billion Counter-Drone Market with AI-Powered Defense Ecosystem: ZenaTech, Inc. (N A S D A Q: ZENA)
FAYETTEVILLE, Ark. - AussieJournal -- Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines. The company was awarded United States utility patent US10655768B2 that covers several key features of the device. This is the third patent awarded to Lineus Medical, which now has two utility patents and one design patent pertaining to SafeBreak Vascular.
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on Aussie Journal
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on Aussie Journal
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
- New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
- Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on Aussie Journal
- UK Financial Ltd Chooses PUMP.FUN App to Launch Maya Meme's Minor-League Meme Coins and Announces Lifetime Airdrop Program
- Boston Industrial Solutions Expands Its Industry-Leading UV Ink Portfolio with the Launch of a Matte Ink - Natron® UVPZ
- Century Fasteners Corp. Exhibiting at 2026 MRO Americas Show – April 21-23, 2026 – Booth #2257
- Blue Sparrow Coffee named Best Matcha in Westword's Best of Denver 2026
- Ocean County College Introduces Pathways to Simplify the Student Journey and Strengthen Career Connections
- Kiko Nation Expands to Apple App Store, Achieving Full Mobile Deployment for Livestock Digital Registry Platform
- The Lawyers' Marketer Launches Claude AI Implementation Service for Law Firms
- Certified Trading Card Association and Collectors MD Launch Healthy Hobby Initiative
- L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
- FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
- HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
- Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor
- PandaGuarantee Launches Rent Guarantor Service in New York City
- The $112M Marketing Lesson Joe Whyte Learned: Why 'More Traffic' Is the Biggest Lie in Digital Marketing



